| Renal benefits of SGLT 2 inhibitors and GLP-1 receptor agonists: evidence supporting a paradigm shift in the medical management of type 2 diabetes V Ninčević, T Omanović Kolarić, H Roguljić, T Kizivat, M Smolić, ... International Journal of Molecular Sciences 20 (23), 5831, 2019 | 69 | 2019 |
| Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update K Duspara, K Bojanic, JI Pejic, L Kuna, TO Kolaric, V Nincevic, R Smolic, ... Journal of Clinical and Translational Hepatology 9 (6), 960, 2021 | 27 | 2021 |
| Drug-induced fatty liver disease: Pathogenesis and treatment TO Kolaric, V Nincevic, L Kuna, K Duspara, K Bojanic, S Vukadin, ... Journal of Clinical and Translational Hepatology 9 (5), 731, 2021 | 20 | 2021 |
| Risk factors contributing to the occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus patients treated with direct-acting antivirals S Kishta, A Tabll, T Omanovic Kolaric, R Smolic, M Smolic Biomedicines 8 (6), 175, 2020 | 11 | 2020 |
| Pretreatment of garlic oil extracts hampers epithelial damage in cell culture model of peptic ulcer disease L Kuna, M Zjalic, T Kizivat, H Roguljic, V Nincevic, T Omanovic Kolaric, ... Medicina 58 (1), 91, 2022 | 6 | 2022 |
| Antimicrobial resistance and antimicrobial stewardship: Before, during and after the COVID-19 pandemic O Khaznadar, F Khaznadar, A Petrovic, L Kuna, A Loncar, ... Microbiology Research 14 (2), 727-740, 2023 | 5 | 2023 |
| Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy V Mihaljević, M Zjalić, T Kizivat, T Omanović Kolarić, M Smolić, E Rođak, ... Biomedicines 10 (11), 2983, 2022 | 5 | 2022 |
| Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug … T Omanovic Kolaric, T Kizivat, V Mihaljevic, M Zjalic, I Bilic-Curcic, L Kuna, ... Current Issues in Molecular Biology 44 (8), 3465-3480, 2022 | 5 | 2022 |
| The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD A Petrovic, D Igrec, K Rozac, K Bojanic, L Kuna, TO Kolaric, V Mihaljevic, ... Current Issues in Molecular Biology 45 (6), 4544-4556, 2023 | 3 | 2023 |
| Pharmacogenomics: sex differences and application in pediatrics I Bozic, T Omanovic, L Kuna, T Kizivat, R Smolic, A Vcev, M Smolic Southeastern European Medical Journal: SEEMEDJ 1 (1), 108-120, 2017 | 3 | 2017 |
| Primary care provider counseling practices about adverse drug reactions and interactions in Croatia N Raguz Lucic, J Jakab, M Smolic, AM Milas, T Omanovic Kolaric, ... Journal of Clinical Medicine 7 (9), 231, 2018 | 2 | 2018 |
| Pharmacogenomics: recent progress, sex gender differences, translation into clinical practice, application in pediatrics and future perspectives M Smolic, I Bozic, T Omanovic, L Kuna, T Kizivat, R Smolic, A Vcev Southeastern European Medical Journal 1 (1), 108-120, 2017 | 2 | 2017 |
| Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update TO Kolaric, L Kuna, M Covic, H Roguljic, A Matic, R Sikora, M Hefer, ... Current Issues in Molecular Biology 45 (5), 4246-4260, 2023 | | 2023 |
| Home-Based Exercise During the Coronavirus Pandemic–A Useful, yet Challenging Treatment Strategy for Improvement of Mental Health, Glycemic Control and COVID-19 Outcomes in … M Cigrovski Berković, M Ivandić, A Mrzljak, V Cigrovski, ... Southeastern European Medical Journal: SEEMEDJ 7 (1), 28-35, 2023 | | 2023 |
| Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study M Ivandic, M Cigrovski Berkovic, K Ormanac, D Sabo, T Omanovic Kolaric, ... International Journal of Environmental Research and Public Health 20 (6), 4966, 2023 | | 2023 |
| EPICATECHIN AS A POTENTIAL HEPATOPROTECTIVE AGENT IN NAFLD M Hefer, A Petrovic, T Omanovic Kolaric, L Kuna Roguljic, T Kizivat, ... 14th International Scientific and Professional Conference With Food to …, 2023 | | 2023 |
| Late Breaking Poster D Igrec, A Petrovic, T Omanovic, L Kuna, K Rozac, M Hefer, R Smolic, ... | | 2023 |
| Utjecaj analoga peptida 1 sličnog glukagonu na mehanizme nastanka lijekovima izazvanog jetrenog oštećenja u staničnim kulturama T Omanović Kolarić Josip Juraj Strossmayer University of Osijek. Faculty of Medicine Osijek, 2022 | | 2022 |
| Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy. Biomedicines 2022, 10, 2983 V Mihaljevic, M Zjalic, T Kizivat, T Omanovic Kolaric, M Smolic, E Rodak, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway T Omanovic Kolaric, V Nincevic, T Kizivat, M Zjalic, L Kuna, I Bili-Curcic, ... 3rd European Fatty Liver Conference, 1-1, 2022 | | 2022 |
